Issue 5, 2024

Lab-on-chip technologies for exploring the gut–immune axis in metabolic disease

Abstract

The continued rise in metabolic diseases such as obesity and type 2 diabetes mellitus poses a global health burden, necessitating further research into factors implicated in the onset and progression of these diseases. Recently, the gut–immune axis, with diet as a main regulator, has been identified as a possible role player in their development. Translation of conventional 2D in vitro and animal models is however limited, while human studies are expensive and preclude individual mechanisms from being investigated. Lab-on-chip technology therefore offers an attractive new avenue to study gut–immune interactions. This review provides an overview of the influence of diet on gut–immune interactions in metabolic diseases and a critical analysis of the current state of lab-on-chip technology to study this axis. While there has been progress in the development of “immuno-competent” intestinal lab-on-chip models, with studies showing the ability of the technology to provide mechanical cues, support longer-term co-culture of microbiota and maintain in vivo-like oxygen gradients, platforms which combine all three and include intestinal and immune cells are still lacking. Further, immune cell types and inclusion of microenvironment conditions which enable in vivo-like immune cell dynamics as well as host-microbiome interactions are limited. Future model development should focus on combining these conditions to create an environment capable of hosting more complex microbiota and immune cells to allow further study into the effects of diet and related metabolites on the gut–immune ecosystem and their role in the prevention and development of metabolic diseases in humans.

Graphical abstract: Lab-on-chip technologies for exploring the gut–immune axis in metabolic disease

Article information

Article type
Critical Review
Submitted
14 Oct 2023
Accepted
06 Jan 2024
First published
16 Jan 2024
This article is Open Access
Creative Commons BY-NC license

Lab Chip, 2024,24, 1266-1292

Lab-on-chip technologies for exploring the gut–immune axis in metabolic disease

A. E. Wheeler, V. Stoeger and R. M. Owens, Lab Chip, 2024, 24, 1266 DOI: 10.1039/D3LC00877K

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements